-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Atea Pharmaceuticals, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q3 2019 to Q2 2024.
- Atea Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $12.7M, a 2.97% increase year-over-year.
- Atea Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $49.8M, a 3.77% increase year-over-year.
- Atea Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $49.4M, a 5.8% increase from 2022.
- Atea Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $46.7M, a 17.9% increase from 2021.
- Atea Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $39.6M, a 431% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)